Active Ingredient(s): Nitroprusside
FDA Approved: * September 8, 1981
Pharm Company: * ABBOTT
Category: Heart (Cardiac)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Nitropress Overview

Sodium nitroprusside is an inorganic compound with the formula Na2[Fe(CN)5NO], usually encountered as the dihydrate, Na2[Fe(CN)5NO]·2H2O.[2] This red-colored sodium salt dissolves in water ethanol to give solutions containing the free complex dianion [Fe(CN)5NO]2−. This compound is used as a drug. In this role it is abbreviated SNP, and it has tradenames like Nitropress. It acts as a drug by releasing nitric oxide; it belongs to the class of NO-releasing drugs as a result. This dru...

Read more Nitropress Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Nitropress Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 25mg/ml, 50mg, 50mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Nitropress: (2 results)

Sorted by National Drug Code
  • 0409-3024 Nitropress 50 mg/2ml Intravenous Injection, Solution, Concentrate by Hospira, Inc.
  • 42998-302 Nitropress 50 mg/2ml Intravenous Injection, Solution, Concentrate by Marathon Pharmaceuticals, LLC

Other drugs which contain Nitroprusside or a similar ingredient: (1 result)